Related Experiment Videos
Phenotype-based risk stratification for deep vein thrombosis in Behçet's disease: a global 10-year longitudinal study
Hiroko Nagafuchi1, Takayasu Ando2, Kimito Kawahata2
1Department of Rheumatology and Allergology, St. Marianna University School of Medicine, Miyamae-ku, Kawasaki, Japan. h3naga@marianna-u.ac.jp.
Objectives:
Vascular involvement, particularly deep vein thrombosis (DVT), is a major cause of morbidity and mortality in Behçet's disease (BD). This study aimed to identify independent risk factors for DVT and establish a robust framework for phenotype-based risk stratification.
Methods:
We conducted a retrospective cohort study using the TriNetX global health research network and identified 19,739 patients with BD. Three independent propensity score-matched cohorts were established to evaluate the impact of intestinal involvement, thrombophlebitis, and antiphospholipid syndrome (APS). A multivariable Cox proportional hazards model was used to identify independent predictors of DVT over a 10-year follow-up. To ensure the robustness of our findings and minimise peri-diagnostic detection bias, a 90-day landmark analysis was performed as a sensitivity analysis.
Results:
Multivariable analysis identified APS (adjusted hazard ratio [aHR] 6.28, 95% confidence interval [CI] 4.56-8.64) and a history of thrombophlebitis (aHR 5.92, 95% CI 4.72-7.41) as the strongest independent predictors of DVT. In the 90-day landmark analysis, these associations remained significant, with persistent risk observed for APS (aHR 5.10) and thrombophlebitis (aHR 2.50), confirming their long-term predictive value. Additional independent predictors included intestinal involvement (defined as non-infective inflammatory colitis; aHR 1.51), obesity (aHR 1.98), glucocorticoid use (aHR 1.78), and male sex (aHR 1.77).
Conclusions:
APS and thrombophlebitis, markers of heightened inflammatory and thrombotic activity at diagnosis, also appear to be persistent indicators of elevated DVT risk in BD. These findings support phenotype-based risk stratification and highlight the need for intensive monitoring and individualised preventive strategies to improve long-term outcomes.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pedigree Analysis